Cipla reported INR67.78B in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
aTyr Pharma USD 2.84M 45.19K Jun/2026
Cara Therapeutics USD 900K 0 Mar/2025
Cipla INR 67.78B 1.82B Sep/2026
Dr.Reddys Laboratories INR 80.47B 3.94B Jun/2026
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Sun Pharmaceuticals INR 114.93B 12.5B Mar/2026
TherapeuticsMD USD 6.7M 551K Sep/2022
UPL INR 201.65B 74.89B Sep/2026